Source: Υπουργείο Υγείας (CY) Revision Year: 2016 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Fenamon SR 20 mg modified release tablets.
| Pharmaceutical Form |
|---|
|
Modified release tablet. Yellow, round, convex modified release tablet. |
Each modified release tablet contains 20 mg of nifedipine.
Excipients with known effect: lactose, sunset yellow.
Each modified release tablet contains 19.00 mg lactose monohydrate and 0.79 mg sunset yellow.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nifedipine |
Nifedipine is a calcium antagonist of the 1,4-dihydropyridine type. Calcium antagonists reduce the transmembranal influx of calcium ions through the slow calcium channel into the cell. As a specific and potent calcium antagonist, nifedipine acts particularly on the cells of the myocardium and the smooth muscle cells of the coronary arteries and the peripheral resistance vessels. The main action of nifedipine is to relax arterial smooth muscle, both in the coronary and peripheral circulation. Nifedipine Tablets are formulated to achieve controlled delivery of nifedipine in a release profile sufficient to enable once-daily administration to be effective in clinical use. |
| List of Excipients |
|---|
|
Lactose monohydrate The film coating consists of: Hypromellose |
White polyvinylchloride film – aluminium foil blisters of ten tablets. Packs, with a patient information leaflet, containing 20, 30 or 50 tablets are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
19938
22/12/2005
| Drug | Countries | |
|---|---|---|
| FENAMON | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
